Miller Matthew P 4
4 · Oncology Institute, Inc. · Filed Dec 20, 2022
Insider Transaction Report
Form 4
Miller Matthew P
Chief Operating Officer
Transactions
- Purchase
Common Stock
2022-12-16$0.95/sh+73,684$70,000→ 175,325 total
Footnotes (1)
- [F1]The purchase of common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, to the extent of 577 shares, with the reporting persons sale of shares of common stock on November 15, 2022. The reporting person has paid to the Issuer the full amount of the profit realized in connection with the short-swing transaction, less transaction costs, calculated in accordance with Section 16(b).